Todd Correll Email & Phone Number

Philadelphia, Pennsylvania, United States

Responsible for leading the development program for Doravirine/Islatravir for the treatment of HIV-1. Core responsibilities include, but not limited to, leading the development team and clinical subteam activities, developing the clinical development strategy, liaising with clinicians, investigators and advocates, timely publication of scientific publications, co-leading activities to address the FDA partial clinical hold on the ISL IND, development of direct reports, and mentoring key talent within the program.

Liver Fibrosis/NASH• Develop worldwide thought leader map for Liver Fibrosis/NASH • Develop and execute Liver Fibrosis/NASH Disease strategy• Develop and execute Liver Fibrosis/NASH Communication & publication strategy• Develop non-registrational data generation strategy/plan for Liver Fibrosis including compassionate use program for BMS-036 & BMS-171• Develop worldwide Liver Fibrosis/NASH advisory board plan• Collaborate across BMS therapeutic areas (HCC and HCV) developing core customer group to drive/advance scientific field within gastroenterology/hepatology disease etiologies• Participate in Liver Fibrosis/NASH Business Development discussions• Assist in development of health outcomes research strategy and data generation plan• Participate in Liver Fibrosis/NASH Development strategic discussions and clinical development plan• Collaborate with worldwide commercial counterpart to support commercial and market access strategies• Manage Liver Fibrosis/NASH Disease Strategy budgetIdiopathic Pulmonary Fibrosis• Develop worldwide thought leader map for Idiopathic Pulmonary Fibrosis• Develop & execute Idiopathic Pulmonary Fibrosis Disease Strategy• Review and participate in Liver Fibrosis and Pulmonary Fibrosis Development Strategies• Develop non-registrational data generation strategy for Idiopathic Pulmonary Fibrosis including compassionate use program for BMS-020• Participate in Fibrosis Development Forum Discussions• Manage Idiopathic Pulmonary Fibrosis Disease Strategy budget

Princeton, Nj

• Lead Worldwide HIV Medical Affairs team to support BMS HIV Portfolio• Participate on HIV Disease Strategy Team• Lead atazanavir development program interacting with senior leadership regarding overall development strategy and execution Successful global regulatory submissions for atazanavir/cobicistat Success US regulatory submission for atazanavir powder• Develop and execute atazanavir research program, including review of atazanavir investigator initiated studies and Phase 4 research• Co-lead development of BMS Virology Communication strategy• Plan and execute HIV Portfolio Communication strategy and publication plan• Developed and executed external communication strategy and plan regarding BMS termination of Virology Discovery Program & termination of licensing agreement for BMS-001• Lead BMS-068, BMS-001 and BMS-176 Global Medical Matrix Team• Develop and execute BMS-068, BMS-001 and BMS-176 Strategic Global Medical Plans • Develop Worldwide HIV advisory board strategies and execution • Review and assist with BMS-001, BMS-068 & BMS-176 development strategies, including development of Phase 2b & 3 research strategy, design of and investigator recommendations for Phase 2b and 3 studies and development of life cycle management strategy• Medical affairs representative for BMS-001, BMS-068 and BMS-176 development teams with senior leadership interactions and governance meetings• Lead BMS-068 and BMS-176 disease strategy and implementation• Develop and implement BMS-068 expanded access program• Support HIV marketing, regulatory, pharmacovigilance and global clinical research • Collaborate and lead key insight gathering with regional HIV and field medical team for HIV investigational agents• Interact with global regulatory agencies for regulatory submissions and other regulatory documents• Liaise with external thought leaders and advocates • Manage Worldwide HIV medical budgets

Medical Affairs Lead for BMS HIV portfolio (see above)In addition to HIV medical affairs responsibilities, lead Medical Affairs responsibilities for HCV including: • Develop and execute daclatasvir, asunaprevir and BMS-325 Global Medical Plan, communication strategy, publication plan, Life Cycle Management Strategy, and expanded access program• Manage daclatasvir/asunaprevir/BMS-325 medical budget

• Lead Global and US Efavirenz Medical Matrix Teams• Develop and execute HIV medical strategies, global and US medical plans, and publication/communication plans• Review and approve post marketing research proposals• Lead HIV competitive landscape activities• Assist with US efavirenz pediatric label submission• Manage efavirenz medical budget• Manage efavirenz medical team• Support marketing, regulatory, pharmacovigilance and global clinical research• Medical review of promotional marketing materials • Support Joint Venture with Gilead for Atripla• Liaise with external thought leaders and advocates

Promoted to Senior Clinical Science Manager July 2010Job responsibilities included:• Develop thought leader relationships• Support marketing and field sales• Lead Adherence and Pharmacokinetic Working Group• Participate on Antiretroviral Therapy Working Group as integrase inhibitor lead• Participated as Medical Affairs lead for PROGRESS Study• Manage Investigator Initiated Studies • Participate in advisory boards• Attend and provide support for medical conferences, including planning medical conference activity for key conferences• Coordinate internal training meeting for new medical affairs personnel• Lead Journal Watch activity

Chapel Hill, Nc

• Provide pharmacotherapy recommendations on adult infectious diseases service and HIV ambulatory care• Provide patient counseling• Manage anti-infective formulary• Secretary of Anti-infective subcommittee• Preceptor for pharmacy students and residents• Program co-director for Infectious Diseases Specialty Resident• Adjunct faculty at University of North Carolina School of Pharmacy• Provide staff in-services